Asfotase alfa therapy for children with hypophosphatasia

Authors

Michael P. Whyte, Washington University School of Medicine in St. Louis
Katherine L. Madson, Shriners Hospital for Children, St. Louis
Dawn Phillips, University of North Carolina at Chapel Hill
Amy L. Reeves, Shriners Hospital for Children, St. Louis
William H. McAlister, Washington University School of Medicine in St. Louis
Amy Yakimoski, University of Manitoba
Karen E. Mack, Shriners Hospital for Children, St. Louis
Kim Hamilton, Children’s Hospital, Winnipeg
Kori Kagan, Children’s Hospital, Winnipeg
Kenji P. Fujita, Alexion Pharmaceuticals Inc., Cheshire, Connecticut
David D. Thompson, Alexion Pharmaceuticals Inc., Cheshire, Connecticut
Scott Moseley, Alexion Pharmaceuticals Inc., Cheshire, Connecticut
Tatjana Odrljin, Alexion Pharmaceuticals Inc., Cambridge, Massachusetts
Cheryl Rockman-Greenberg, University of Manitoba

Journal

JCI Insight

Publication Date

6-16-2016

Volume

1

Issue

9

First Page

e85971

Document Type

Open Access Publication

DOI

10.1172/jci.insight.85971

Rights and Permissions

Whyte MP, Madson KL, Phillips D, Reeves AL, McAlister WH, Yakimoski A, Mack KE, Hamilton K, Kagan K, Fujita KP, Thompson DD, Moseley S, Odrljin T, Rockman-Greenberg C. Asfotase alfa therapy for children with hypophosphatasia. JCI Insight. 2016 Jun 16;1(9):e85971. doi: 10.1172/jci.insight.85971.

Recommended Citation

Whyte, Michael P.; Madson, Katherine L.; Phillips, Dawn; Reeves, Amy L.; McAlister, William H.; Yakimoski, Amy; Mack, Karen E.; Hamilton, Kim; Kagan, Kori; Fujita, Kenji P.; Thompson, David D.; Moseley, Scott; Odrljin, Tatjana; and Rockman-Greenberg, Cheryl, "Asfotase alfa therapy for children with hypophosphatasia." JCI Insight. 1, 9. e85971 (2016).
https://digitalcommons.wustl.edu/open_access_pubs/10791